APA (7th ed.) Citation

Ács, B., Zámbó, V., Vízkeleti, L., Szász, A. M., Madaras, L., Szentmártoni, G., . . . Tőkés, A. (2017). Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy. Diagnostic pathology, 12(1), 20. https://doi.org/10.1186/s13000-017-0608-5

Chicago Style (17th ed.) Citation

Ács, Balázs, et al. "Ki-67 as a Controversial Predictive and Prognostic Marker in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy." Diagnostic Pathology 12, no. 1 (2017): 20. https://doi.org/10.1186/s13000-017-0608-5.

MLA (9th ed.) Citation

Ács, Balázs, et al. "Ki-67 as a Controversial Predictive and Prognostic Marker in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy." Diagnostic Pathology, vol. 12, no. 1, 2017, p. 20, https://doi.org/10.1186/s13000-017-0608-5.